Prestige Consumer Healthcare has agreed to acquire a portfolio of brands from Foundation Consumer Healthcare for $1.045 billion. The deal includes the popular Breathe Right nasal strips, a staple in over-the-counter respiratory care products. This acquisition represents a significant expansion of Prestige's consumer health offerings.

The transaction will strengthen Prestige's position in the OTC healthcare market, where Breathe Right has established itself as a leading brand for nasal congestion relief. Foundation Consumer Healthcare, a private company, has built a portfolio of health and wellness brands that complement Prestige's existing product lineup. The $1.045 billion price tag reflects the strategic value of these brands to Prestige's growth strategy.

This deal comes as consumer healthcare companies seek to consolidate market share through strategic acquisitions. By adding Breathe Right and other Foundation brands to its portfolio, Prestige aims to enhance its competitive position in the rapidly evolving OTC healthcare sector. The acquisition is expected to close in the coming months, pending regulatory approval.